World Influenza Vaccines Market - Opportunities and Forecasts, 2017-2023 Influenza is a type of seasonal or pandemic condition causing fever, coryza, cough, headache, and malaise. The severity of influenza symptoms varies across age groups and type of influenza. According to the World Health Organization (WHO), approximately, 3 to 5 million people are prone to seasonal epidemics, annually. The growing number of ageing population and an increase in the frequency of seasonal influenza outbreak supplement the demand for influenza vaccines across the healthcare industry. Intellectual property rights are providing security to the patent holders, thereby, increases their market share. However, the upcoming patent expirations for top influenza vaccines and the growing popularity of influenza drugs as over the counter (OTC) products would provide an opportunity for generic manufacturers. On the contrary, limited awareness regarding the availability of novel versions of vaccines and unclear reimbursement facilities hamper the growth of the influenza vaccines market. Furthermore, high tolerance of viral strains towards conventional compositions would limit the adoption of influenza vaccines. However, collective efforts of governments, non-profitable organizations and pharmaceutical companies would help boost advance research and development programs, which would subsequently lead to a reduction in the cost of vaccines and also bring clarity in the reimbursement and regulatory guidelines.
Get sample copy of this report at : https://www.alliedmarketresearch.com/request-tocand-sample/1437